Xian‐E Peng

1.2k total citations
69 papers, 846 citations indexed

About

Xian‐E Peng is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Xian‐E Peng has authored 69 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 18 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Xian‐E Peng's work include Liver Disease Diagnosis and Treatment (32 papers), Esophageal Cancer Research and Treatment (10 papers) and Alcohol Consumption and Health Effects (9 papers). Xian‐E Peng is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Esophageal Cancer Research and Treatment (10 papers) and Alcohol Consumption and Health Effects (9 papers). Xian‐E Peng collaborates with scholars based in China, Australia and Taiwan. Xian‐E Peng's co-authors include Yunli Wu, Zhijian Hu, Lin Xu, Xu Lin, Bingjie Guan, Yibing Zhu, Xiaoli Yan, Jing Zheng, Qingqing Lu and Zheng Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Xian‐E Peng

64 papers receiving 834 citations

Peers

Xian‐E Peng
Natalia Nuño‐Lámbarri Mexico
Jing Hou China
Keishi Kanno Japan
Svenja Sydor Germany
Sara Ceccarelli Italy
Shufei Zang China
Tommy Pacana United States
Yaşar Çolak Türkiye
Ghassan M. Hammoud United States
María Valeria Razori Argentina
Natalia Nuño‐Lámbarri Mexico
Xian‐E Peng
Citations per year, relative to Xian‐E Peng Xian‐E Peng (= 1×) peers Natalia Nuño‐Lámbarri

Countries citing papers authored by Xian‐E Peng

Since Specialization
Citations

This map shows the geographic impact of Xian‐E Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian‐E Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian‐E Peng more than expected).

Fields of papers citing papers by Xian‐E Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xian‐E Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian‐E Peng. The network helps show where Xian‐E Peng may publish in the future.

Co-authorship network of co-authors of Xian‐E Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Xian‐E Peng. A scholar is included among the top collaborators of Xian‐E Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian‐E Peng. Xian‐E Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xian‐E, et al.. (2024). Association Between Serum Uric Acid to Creatinine Ratio and Metabolic-Associated Fatty Liver Disease in Southeast China (TyG-BMI as a Potential Mediator). Diabetes Metabolic Syndrome and Obesity. Volume 17. 4711–4720. 2 indexed citations
2.
Luo, Chaoxi, Ke Lv, Xian‐E Peng, & Xuan Jia. (2024). HPR58 Accessibility and Reimbursement Coverage of Rare Disease Drugs in China: Insights From the China's Lists of Rare Diseases. Value in Health. 27(12). S287–S287.
3.
4.
Lin, Zheng, Jian Jiang, Jianwen Wang, et al.. (2022). Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma. Gastroenterology report. 11. goad022–goad022. 4 indexed citations
5.
Xie, Xiaoxu, et al.. (2022). The spatiotemporal correlation of PM2.5 concentration on esophageal cancer hospitalization rate in Fujian province of China. Environmental Science and Pollution Research. 29(44). 67325–67335. 3 indexed citations
6.
Wang, Dong, et al.. (2022). Hepatoprotective drugs for prevention of liver injury resulting from anti-tuberculosis treatment: A meta-analysis of cohort studies. SHILAP Revista de lepidopterología. 1(3). 154–162. 3 indexed citations
7.
Huang, Xianhua, et al.. (2022). Association of food intake with a risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study. Gastroenterology report. 11. goad054–goad054. 2 indexed citations
8.
Cai, Xiaoling, Fa Chen, Weizhong Jiang, et al.. (2022). A novel inflammation-related prognostic biomarker for predicting the disease-free survival of patients with colorectal cancer. World Journal of Surgical Oncology. 20(1). 79–79. 7 indexed citations
9.
10.
Yuan, Ping, Jianjun Xiang, Matthew Borg, et al.. (2020). Analysis of lifetime death probability for major causes of death among residents in China. BMC Public Health. 20(1). 1090–1090. 2 indexed citations
11.
Zheng, Jing, et al.. (2020). The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies. Epidemiology and Infection. 148. e290–e290. 16 indexed citations
12.
He, Fei, Yun He, Yunli Wu, et al.. (2019). Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population. BMJ Open. 9(3). e026854–e026854. 16 indexed citations
13.
14.
Gan, Rui-Huan, Lisong Lin, Li Huang, et al.. (2019). <p>FLI-06 Intercepts Notch Signaling And Suppresses The Proliferation And Self-renewal Of Tongue Cancer Cells</p>. OncoTargets and Therapy. Volume 12. 7663–7674. 13 indexed citations
15.
Wu, Yunli, et al.. (2017). Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression. Cellular Physiology and Biochemistry. 44(6). 2243–2255. 17 indexed citations
16.
Peng, Xian‐E, et al.. (2015). Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels. PLoS ONE. 10(10). e0139417–e0139417. 16 indexed citations
17.
Peng, Xian‐E, et al.. (2013). The roles of HBV infection and host factors in ultrasound-diagnosed fatty liver: a case-control study.. PubMed. 60(127). 1698–704. 3 indexed citations
18.
Wu, Yunli, Dong Wang, Xian‐E Peng, et al.. (2013). Epigenetic silencing of NAD(P)H:quinone oxidoreductase 1 by hepatitis B virus X protein increases mitochondrial injury and cellular susceptibility to oxidative stress in hepatoma cells. Free Radical Biology and Medicine. 65. 632–644. 31 indexed citations
19.
Peng, Xian‐E, et al.. (2010). A case control study on the relationship between Wuyishan clif tea and esophageal cancer.. 22(5). 323–325. 1 indexed citations
20.
Peng, Xian‐E. (2003). Study on Geographic Characteristics of Esophageal Cancer in Fujian Province. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Nuño‐Lámbarri Breakdown of academic impact, for papers by Jing Hou Breakdown of academic impact, for papers by Keishi Kanno Breakdown of academic impact, for papers by Svenja Sydor Breakdown of academic impact, for papers by Sara Ceccarelli Breakdown of academic impact, for papers by Shufei Zang Breakdown of academic impact, for papers by Tommy Pacana Breakdown of academic impact, for papers by Yaşar Çolak Breakdown of academic impact, for papers by Ghassan M. Hammoud Breakdown of academic impact, for papers by María Valeria Razori
Rankless by CCL
2026